Dennis Karl Huang Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dennis Karl Huang.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dennis Karl Huang. Dennis Karl Huang is EVP & Chief Tech Ops Officer in Ultragenyx Pharmaceutical Inc. ($RARE) and SVP & Chief TechOps Officer in Ultragenyx Pharmaceutical Inc. ($RARE) and SVP and Chief Tech Ops Officer in Ultragenyx Pharmaceutical Inc. ($RARE).
Latest Insider Trading Transactions of Dennis Karl Huang
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Sell | S | 113.68 | 363 | 41,266 | 40,506 | 40.9 K to 40.5 K (-0.89 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Option Exercise | A | 142.47 | 11,000 | 1,567,170 | 11,000 | |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Sell | S | 138.18 | 4,255 | 587,956 | 40,761 | 45 K to 40.8 K (-9.45 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 4,636 | 0 | 44,835 | 40.2 K to 44.8 K (+11.53 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 5,500 | 0 | 40,199 | 34.7 K to 40.2 K (+15.85 %) |
| Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Sell | S | 88.00 | 262 | 23,056 | 34,699 | 35 K to 34.7 K (-0.75 %) |
| Jun 03 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 69.38 | 262 | 18,178 | 34,961 | 35.2 K to 35 K (-0.74 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 66.26 | 248 | 16,432 | 34,979 | 35.2 K to 35 K (-0.70 %) |
| Apr 21 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 58.57 | 248 | 14,525 | 35,227 | 35.5 K to 35.2 K (-0.70 %) |
| Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Option Exercise | A | 56.08 | 22,000 | 1,233,760 | 22,000 | |
| Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 56.08 | 1,779 | 99,766 | 35,475 | 37.3 K to 35.5 K (-4.78 %) |
| Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 5,634 | 0 | 37,013 | 31.4 K to 37 K (+17.95 %) |
| Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 7,800 | 0 | 31,379 | 23.6 K to 31.4 K (+33.08 %) |
| Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 1,434 | 0 | 23,579 | 22.1 K to 23.6 K (+6.48 %) |
| Jun 04 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 54.93 | 260 | 14,282 | 22,145 | 22.4 K to 22.1 K (-1.16 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 1,434 | 0 | 22,405 | 21 K to 22.4 K (+6.84 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 67.99 | 649 | 44,126 | 20,971 | 21.6 K to 21 K (-3.00 %) |
| Apr 23 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 64.43 | 248 | 15,979 | 21,445 | 21.7 K to 21.4 K (-1.14 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Option Exercise | A | 67.55 | 20,000 | 1,351,000 | 20,000 | |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 67.55 | 607 | 41,003 | 21,711 | 22.3 K to 21.7 K (-2.72 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 6,000 | 0 | 22,318 | 16.3 K to 22.3 K (+36.77 %) |
| Jun 04 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 73.73 | 260 | 19,170 | 16,124 | 16.4 K to 16.1 K (-1.59 %) |
| May 08 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 54.50 | 649 | 35,371 | 16,384 | 17 K to 16.4 K (-3.81 %) |
| Apr 19 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 1,431 | 0 | 16,850 | 15.4 K to 16.9 K (+9.28 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Option Exercise | A | 48.43 | 25,000 | 1,210,750 | 25,000 | |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 48.43 | 205 | 9,928 | 15,419 | 15.6 K to 15.4 K (-1.31 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 4,500 | 0 | 15,624 | 11.1 K to 15.6 K (+40.45 %) |
| Jun 01 2017 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 56.61 | 282 | 15,964 | 10,939 | 11.2 K to 10.9 K (-2.51 %) |
| May 08 2017 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 61.08 | 705 | 43,061 | 11,221 | 11.9 K to 11.2 K (-5.91 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Option Exercise | A | 88.80 | 15,000 | 1,332,000 | 15,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 2,000 | 0 | 11,795 | 9.8 K to 11.8 K (+20.42 %) |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | SVP and Chief Tech ... | Option Exercise | A | 70.57 | 17,800 | 1,256,146 | 17,800 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | SVP and Chief Tech ... | Grant | A | 0.00 | 3,000 | 0 | 9,795 | 6.8 K to 9.8 K (+44.15 %) |
| May 09 2016 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | SVP and Chief Tech ... | Payment of Exercise | F | 62.45 | 705 | 44,027 | 6,795 | 7.5 K to 6.8 K (-9.40 %) |
| Jul 20 2015 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | SVP and Chief Tech ... | Option Exercise | A | 124.87 | 15,000 | 1,873,050 | 15,000 | |
| May 07 2015 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | SVP & Chief TechOps ... | Option Exercise | A | 62.63 | 60,000 | 3,757,800 | 60,000 | |
| May 07 2015 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | SVP & Chief TechOps ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Page: 1